Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib

Yuriko Yamamura, Yoshinori Matsumoto, Yosuke Asano, Yu Katayama, Keigo Hayashi, Keiji Ohashi, Michiko Morishita, Haruki Watanabe, Mariko Takano-Narazaki, Ken Ei Sada, Jun Wada

Research output: Contribution to journalLetter

Original languageEnglish
Article numberrkz050
JournalRheumatology Advances in Practice
Volume4
Issue number1
DOIs
Publication statusPublished - Feb 6 2020

ASJC Scopus subject areas

  • Rheumatology

Cite this

Yamamura, Y., Matsumoto, Y., Asano, Y., Katayama, Y., Hayashi, K., Ohashi, K., Morishita, M., Watanabe, H., Takano-Narazaki, M., Sada, K. E., & Wada, J. (2020). Refractory Takayasu arteritis responding to the oral Janus kinase inhibitor, tofacitinib. Rheumatology Advances in Practice, 4(1), [rkz050]. https://doi.org/10.1093/rap/rkz050